FDA.reportPublic FDA data

NRAS gene mutation IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used to monitor or predict the neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS gene) mutation status of a tumour tissue specimen.
GUDID devices
1
Last updated
2025-03-05 15:17:00

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB26690NRAS control slidesBIO SB, INC.Control Slides, 5 2020-06-01